院外心脏骤停中声门上气道装置与气管插管策略对功能结局的影响:AIRWAYS-2随机临床试验
AIRWAYS-2多中心整群随机临床试验纳入英格兰4个急救服务机构的9296例成人非创伤性院外心脏骤停患者,由参与急救人员随机采用声门上气道装置(SGA组4886例)或气管插管(TI组4410例)作为初始高级气道管理策略。主要终点为出院或30天改良Rankin量表评分0-3分(良好结局),SGA组6.4% vs TI组6.8%(校正风险差-0.6%,95%CI -1.6%至0.4%),无显著差异。SGA组初始通气成功率87.4% vs TI组79.0%(校正风险差8.3%,95%CI 6.3%至10.2%),但TI组接受高级气道管理的比例更低(77.6% vs 85.2%)。反流和误吸两组无显著差异。
要点
- 主要终点:SGA组4882例中311例(6.4%)vs TI组4407例中300例(6.8%)达到良好功能结局(mRS 0-3),校正风险差-0.6%(95%CI -1.6%至0.4%),无显著差异。
- 初始通气成功:SGA组4868例中4255例(87.4%)vs TI组4397例中3473例(79.0%),校正风险差8.3%(95%CI 6.3%至10.2%)。
- TI组接受高级气道管理的比例低于SGA组:3419/4404(77.6%)vs 4161/4883(85.2%)。
- 反流:SGA组4865例中1268例(26.1%)vs TI组4372例中1072例(24.5%),校正风险差1.4%(95%CI -0.6%至3.4%),无显著差异。
- 误吸:SGA组4824例中729例(15.1%)vs TI组4337例中647例(14.9%),校正风险差0.1%(95%CI -1.5%至1.8%),无显著差异。
适用人群与场景
- 年龄18岁及以上的成人非创伤性院外心脏骤停患者,由参与研究的急救人员治疗,在豁免知情同意下自动纳入。
- 研究在英格兰4个急救服务机构进行,服务约2100万人口,纳入时间为2015年6月至2017年8月,随访至2018年2月。
处置流程与药物剂量
- 急救人员按1:1随机分为使用气管插管(764名急救人员)或声门上气道装置(759名急救人员)作为初始高级气道管理策略。
研究设计与关键结果
- 多中心整群随机临床试验,纳入9296例患者(SGA组4886例,TI组4410例),中位年龄73岁,女性3373例(36.3%),9289例患者有改良Rankin量表评分。
- 主要终点良好功能结局(mRS 0-3):SGA组311/4882(6.4%)vs TI组300/4407(6.8%),校正风险差-0.6%(95%CI -1.6%至0.4%)。
- 初始通气成功:SGA组4255/4868(87.4%)vs TI组3473/4397(79.0%),校正风险差8.3%(95%CI 6.3%至10.2%)。
- 接受高级气道管理:TI组3419/4404(77.6%)vs SGA组4161/4883(85.2%)。
- 反流:SGA组1268/4865(26.1%)vs TI组1072/4372(24.5%),校正风险差1.4%(95%CI -0.6%至3.4%);误吸:SGA组729/4824(15.1%)vs TI组647/4337(14.9%),校正风险差0.1%(95%CI -1.5%至1.8%),均无显著差异。
证据类型、等级与局限
- 研究类型:多中心整群随机临床试验(TRIAL REGISTRATION: ISRCTN标识符08256118)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在成人非创伤性院外心脏骤停中,初始采用声门上气道装置策略与气管插管策略相比,未获得更有利的30天功能结局。
- 声门上气道装置策略的初始通气成功率高于气管插管策略(87.4% vs 79.0%),但气管插管策略下实际接受高级气道管理的患者比例更低(77.6% vs 85.2%)。
- 两种策略的反流和误吸发生率无显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The optimal approach to airway management during out-of-hospital cardiac arrest is unknown.
OBJECTIVE: To determine whether a supraglottic airway device (SGA) is superior to tracheal intubation (TI) as the initial advanced airway management strategy in adults with nontraumatic out-of-hospital cardiac arrest.
DESIGN, SETTING, AND PARTICIPANTS: Multicenter, cluster randomized clinical trial of paramedics from 4 ambulance services in England responding to emergencies for approximately 21 million people. Patients aged 18 years or older who had a nontraumatic out-of-hospital cardiac arrest and were treated by a participating paramedic were enrolled automatically under a waiver of consent between June 2015 and August 2017; follow-up ended in February 2018.
INTERVENTIONS: Paramedics were randomized 1:1 to use TI (764 paramedics) or SGA (759 paramedics) as their initial advanced airway management strategy.
MAIN OUTCOMES AND MEASURES: The primary outcome was modified Rankin Scale score at hospital discharge or 30 days after out-of-hospital cardiac arrest, whichever occurred sooner. Modified Rankin Scale score was divided into 2 ranges: 0-3 (good outcome) or 4-6 (poor outcome; 6 = death). Secondary outcomes included ventilation success, regurgitation, and aspiration.
RESULTS: A total of 9296 patients (4886 in the SGA group and 4410 in the TI group) were enrolled (median age, 73 years; 3373 were women [36.3%]), and the modified Rankin Scale score was known for 9289 patients. In the SGA group, 311 of 4882 patients (6.4%) had a good outcome (modified Rankin Scale score range, 0-3) vs 300 of 4407 patients (6.8%) in the TI group (adjusted risk difference [RD], -0.6% [95% CI, -1.6% to 0.4%]). Initial ventilation was successful in 4255 of 4868 patients (87.4%) in the SGA group compared with 3473 of 4397 patients (79.0%) in the TI group (adjusted RD, 8.3% [95% CI, 6.3% to 10.2%]). However, patients randomized to receive TI were less likely to receive advanced airway management (3419 of 4404 patients [77.6%] vs 4161 of 4883 patients [85.2%] in the SGA group). Two of the secondary outcomes (regurgitation and aspiration) were not significantly different between groups (regurgitation: 1268 of 4865 patients [26.1%] in the SGA group vs 1072 of 4372 patients [24.5%] in the TI group; adjusted RD, 1.4% [95% CI, -0.6% to 3.4%]; aspiration: 729 of 4824 patients [15.1%] vs 647 of 4337 patients [14.9%], respectively; adjusted RD, 0.1% [95% CI, -1.5% to 1.8%]).
CONCLUSIONS AND RELEVANCE: Among patients with out-of-hospital cardiac arrest, randomization to a strategy of advanced airway management with a supraglottic airway device compared with tracheal intubation did not result in a favorable functional outcome at 30 days.
TRIAL REGISTRATION: ISRCTN Identifier: 08256118.
参考来源
- Benger JR, Kirby K, Black S, et al. Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial. JAMA. 2018. PMID: 30167701. doi:10.1001/jama.2018.11597
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。